Translation, Adaptation, and Validation of Revised Colorectal Cancer Perception and Screening Instrument among First-Degree Relatives of People with Colorectal Cancer in China

在中国结直肠癌患者一级亲属中对修订版结直肠癌认知和筛查工具进行翻译、改编和验证

阅读:2

Abstract

OBJECTIVE: The purpose of the study was to translate and validate the psychometric properties of the Revised Colorectal Cancer Perception and Screening (RCRCPS) instrument for the first-degree relatives (FDRs) of people with colorectal cancer (CRC) in China. METHODS: The translation, adaptation, and validation guideline developed by Sousa and Rojjanasrirat was used to guide this study. All items from the Colorectal Cancer Perception and Screening (CRCPS) instrument and three items from the Perceived Barriers Questionnaire were combined and further adapted for a colonoscopy test, resulting in RCRCPS. The resultant RCRCPS was translated from English to Chinese through forward- and backward-translation methods, and a panel review was conducted to examine its content validity. The RCRCPS (simplified Chinese version) was then tested with a convenience sample of 197 Chinese FDRs of patients with CRC. Validity was tested through confirmatory factor analysis (CFA) and discriminative validity, and reliability was assessed using Cronbach's α and test-retest reliability. RESULTS: The content validity index (CVI) of the RCRCPS (simplified Chinese version) was satisfactory (item CVI = 0.80-1 and scale CVI = 0.92). The results demonstrated acceptable internal consistency (Cronbach's α = 0.74-0.87) and test-retest reliability in a 4-week interval (intraclass coefficient = 0.53-0.84). CFA revealed that the RCRCPS (simplified Chinese version) conformed to the four-factor model suggested by the original version (Chi-square/degree of freedom = 1.326, root-mean-square error of approximation = 0.041, comparative fit index = 0.904, Tucker-Lewis index = 0.896, and standardized root mean square residual = 0.684). CONCLUSIONS: The 38-item simplified Chinese version of RCRCPS demonstrated acceptable reliability and validity. Healthcare professionals may use this instrument in the development and evaluation of interventions to promote colonoscopy screening among people at an increased risk of developing CRC.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。